Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials.
Saved in:
| Title: | Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials. |
|---|---|
| Authors: | Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois. Electronic address: APaller@nm.org., Siegfried EC; Department of Pediatrics, Saint Louis University, St. Louis, Missouri; Cardinal Glennon Children's Hospital, St. Louis, Missouri., Cork MJ; Department of Infection, Immunity and Cardiovascular Disease, Sheffield Dermatology Research, University of Sheffield, Sheffield, United Kingdom; Children's Hospital, Sheffield, United Kingdom., Kabashima K; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Arkwright PD; Lydia Becker Institute of Immunology & Inflammation, University of Manchester, Manchester, United Kingdom., Gębska E; DERMAPOLIS Medical Dermatology Center, Chorzów, Poland., Chen Z; Regeneron Pharmaceuticals Inc, Tarrytown, New York., Zahn J; Regeneron Pharmaceuticals Inc, Tarrytown, New York., Rossi AB; Sanofi, Cambridge, Massachusetts. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2025 Oct; Vol. 93 (4), pp. 1066-1070. Date of Electronic Publication: 2025 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40441387 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois. Electronic address: APaller@nm.org.<br /><searchLink fieldCode="AU" term="%22Siegfried+EC%22">Siegfried EC</searchLink>; Department of Pediatrics, Saint Louis University, St. Louis, Missouri; Cardinal Glennon Children's Hospital, St. Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Cork+MJ%22">Cork MJ</searchLink>; Department of Infection, Immunity and Cardiovascular Disease, Sheffield Dermatology Research, University of Sheffield, Sheffield, United Kingdom; Children's Hospital, Sheffield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kabashima+K%22">Kabashima K</searchLink>; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Arkwright+PD%22">Arkwright PD</searchLink>; Lydia Becker Institute of Immunology & Inflammation, University of Manchester, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gębska+E%22">Gębska E</searchLink>; DERMAPOLIS Medical Dermatology Center, Chorzów, Poland.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Regeneron Pharmaceuticals Inc, Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Zahn+J%22">Zahn J</searchLink>; Regeneron Pharmaceuticals Inc, Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Rossi+AB%22">Rossi AB</searchLink>; Sanofi, Cambridge, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2025 Oct; Vol. 93 (4), pp. 1066-1070. <i>Date of Electronic Publication: </i>2025 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40441387 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaad.2025.05.1422 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1066 Titles: – TitleFull: Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Paller AS – PersonEntity: Name: NameFull: Siegfried EC – PersonEntity: Name: NameFull: Cork MJ – PersonEntity: Name: NameFull: Kabashima K – PersonEntity: Name: NameFull: Arkwright PD – PersonEntity: Name: NameFull: Gębska E – PersonEntity: Name: NameFull: Chen Z – PersonEntity: Name: NameFull: Zahn J – PersonEntity: Name: NameFull: Rossi AB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-6787 Numbering: – Type: volume Value: 93 – Type: issue Value: 4 Titles: – TitleFull: Journal of the American Academy of Dermatology Type: main |
| ResultId | 1 |
